Lista de obras - Min Shi - Dominio Público Uruguay

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

artículo científico publicado en 2017

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

artículo científico publicado en 2008

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

artículo científico publicado en 2016

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

artículo científico publicado en 2010

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

artículo científico publicado en 2015

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

artículo científico publicado en 2015

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

artículo científico publicado en 2013

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

artículo científico publicado en 2011

Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease

artículo científico publicado en 2015

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.

artículo científico publicado en 2014

Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule

artículo científico publicado en 2000

Glycoproteomics in neurodegenerative diseases

artículo científico publicado en 2010

Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein

artículo científico publicado en 2010

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

artículo científico publicado en 2009

Identification of proteins in human substantia nigra

artículo científico

Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.

artículo científico publicado en 2015

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

artículo científico publicado en 2013

Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease

artículo científico publicado en 2017

Mortalin: a protein associated with progression of Parkinson disease?

artículo científico publicado en 2008

Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity

artículo científico publicado en 2015

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

artículo científico publicado en 2014

Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease

artículo científico publicado en 2014

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

artículo científico publicado en 2008

Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery

artículo científico publicado en 2015

Quantitative Characterization of Glycoproteins in Neurodegenerative Disorders Using iTRAQ ⬇️

artículo científico publicado el 1 de enero de 2013

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion

artículo científico publicado en 2010

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein

artículo científico publicado en 2009

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

artículo científico publicado en 2010

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

artículo científico publicado el 1 de enero de 2011

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

artículo científico publicado en 2011

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

artículo científico publicado en 2010

Targeted discovery and validation of plasma biomarkers of Parkinson's disease

artículo científico publicado en 2014

Tau Proteins Cross the Blood-Brain Barrier

artículo científico publicado en 2016

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease

artículo científico publicado en 2016

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2013

Lista de obras de Min Shi

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.

Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule

Glycoproteomics in neurodegenerative diseases

Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

Identification of proteins in human substantia nigra

Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease

Mortalin: a protein associated with progression of Parkinson disease?

Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery

Quantitative Characterization of Glycoproteins in Neurodegenerative Disorders Using iTRAQ ⬇️

Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Targeted discovery and validation of plasma biomarkers of Parkinson's disease

Tau Proteins Cross the Blood-Brain Barrier

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease

α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment